| Financial Year |
March 31 2023 |
| Monetary Funds |
3,431,468,510.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
508,333,035.17 |
| Advances to Suppliers |
257,415,253.35 |
| Other Receivables |
1,894,647,839.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,371,577,766.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
116,416,143.69 |
| Total Current Assets |
10,627,942,049.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
139,579,008.60 |
| Investment Properties |
10,749,850.27 |
| Fixed Assetes |
1,032,329,368.60 |
| Under-construction Projects |
92,817,923.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
149,608,613.39 |
| R&D expenses |
28,995,769.65 |
| Goodwill |
155,590,269.94 |
| Long-Term Deferred and Prepaid Expenses |
23,498,636.58 |
| Deferred Income Tax Assets |
36,951,373.70 |
| Other Non-Current Assets |
18,557,922.81 |
| Sub-Total of Non-Current Assets |
1,804,545,779.04 |
| Total Assets |
12,432,487,828.70 |
| Short-Term Loans |
1,589,006,083.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
528,453,805.11 |
| Accounts Payable |
797,325,314.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
90,927,611.66 |
| Taxes Payable |
114,485,456.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
419,119,543.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,643,622,732.12 |
| Other Current Liabilities |
34,576,693.76 |
| Sub-Total of Current Liabilities |
6,213,452,163.65 |
| Long-term Loans |
1,582,119,900.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,234,253.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,666,433,236.55 |
| Total Liabilities |
7,879,885,400.20 |
| Paid-In Capital(Or Share Stock) |
1,016,568,775.00 |
| Capital Surplus |
618,053,765.56 |
| Surplus Reserve |
187,674,481.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,023,672,372.78 |
| Minority Stockholder's Interest |
706,325,981.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,846,276,446.64 |
| Owner's Equity（Stockholder's Equity） |
4,552,602,428.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,432,487,828.70 |
